-
Cyanin Chloride in a HaCaT Psoriasis Model
2026-09-11
A 2024 study examined cyanin chloride in chemical antioxidant assays, macrophage inflammation experiments, and a cytokine-induced HaCaT psoriasis model. Its main contribution was to connect reduced inflammatory signaling, STAT3 modulation, improved transepithelial resistance, and increased filaggrin expression, while leaving clinical efficacy and compound identity questions for further study.
-
GLT-1–CB1–CREB Signaling in Traumatic Brain Injury
2026-09-11
This 2025 Biomolecules study identifies a mechanistic link between elevated 2-AG, CB1-CREB signaling, reduced astrocytic GLT-1, and secondary neuronal injury after traumatic brain injury. Its pharmacological and behavioral data suggest that restoring glutamate clearance may reduce apoptosis and cognitive dysfunction, while also defining important limits for translation beyond mouse models.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-09-10
Hao et al. developed ICG-MOF-SS-AUNP12, a zirconium-based metal–organic framework that combines near-infrared photothermal therapy with glutathione-responsive PD-1/PD-L1 blockade. The study shows how a redox-sensitive nanoplatform can couple tumor-cell heating with dendritic-cell maturation and immune activation, while also defining important considerations for translating related imaging dyes into therapeutic workflows.
-
Cathepsin B inhibitor CA-074: Practical Guide
2026-09-10
Cathepsin B inhibitor CA-074 (SKU A1926) is a biochemical and cell-study tool for testing cathepsin B-dependent proteolysis in cancer, neurodegeneration, and immune-response models. Its dossier supports selective enzyme inhibition and defined handling conditions, but it should not be treated as a universal cell-permeable probe or used to infer disease efficacy without model-specific controls.
-
TREM2, Microglia, and Autoimmune Uveitis
2026-09-09
A 2026 study identifies TREM2 as an anti-inflammatory regulator of microglia in experimental autoimmune uveitis, linking its activity to suppression of ERK/p38 signaling. The work combines mouse disease models, BV2-cell perturbation, immune phenotyping, and RNA sequencing to connect retinal inflammation with adaptive Th1, Th17, and Treg imbalance.
-
Amikacin (BAY416651) in CRE Resistance Research
2026-09-09
Amikacin (BAY416651) combines a defined bacterial protein synthesis mechanism with practical value in isolate-level resistance studies. Its strongest use-case is a mechanism-resolved workflow that connects susceptibility testing with carbapenemase genotyping, plasmid localization, and transmission analysis.
-
Clathrin-Mediated Entry of Type III Grass Carp Reovirus
2026-09-08
Wang et al. combined pharmacological inhibition, transmission electron microscopy, and quantitative PCR to define how genotype III grass carp reovirus enters cultured fish cells. Their results identify a dynamin-dependent, acidification-sensitive clathrin pathway and show that amiloride did not inhibit viral entry under the tested conditions, an important distinction for interpreting sodium channel and endocytosis experiments.
-
(R,S)-Anatabine in Amyloid Research
2026-09-08
Anatabine is a research compound that lowers amyloid-beta generation through reported effects on APP beta-cleavage and BACE-1 expression. (R,S)-Anatabine supports controlled in vitro and in vivo Alzheimer's disease model workflows, but the available dossier does not establish clinical efficacy or a direct catalytic BACE-1 binding mechanism.
-
Rhodamine 123: Separating Efflux from Uptake
2026-09-07
Rhodamine 123 (chloride) is more than a fluorescent efflux probe: its signal integrates passive entry, OATP1A2-associated uptake, ABCB1/MDR1 efflux, and intracellular handling. This evidence-led guide explains how to interpret the dye without confusing ABCB1 activity with ABCG2-mediated drug resistance.
-
Rice Stripe Virus NS3 Rewires Host Signaling
2026-09-05
The reference study shows that Rice stripe virus NS3 changes its interaction and phosphorylation behavior during infection to balance antiviral suppression, host damage, and transmission. Its stage-dependent control of the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway provides a mechanistic model for virus–plant–vector co-survival and a useful framework for designing pathway-resolved infection experiments.
-
IWP-2 Beyond Oncology: Designing Wnt Assays
2026-09-05
IWP-2 is a Wnt production inhibitor that enables causal analysis of Porcupine-dependent signaling rather than simple endpoint screening. This article connects its cancer research evidence with cell-type-aware assay design inspired by epigenetic findings in developing cortical interneurons.
-
Lyso-Tracker Red: Reliable Live-Cell Assays
2026-09-04
Learn how Lyso-Tracker Red, SKU B8814, supports reproducible lysosome labeling in live cells, fluorescence imaging, and flow-cytometry workflows. This scenario-based guide covers compatibility, protocol controls, interpretation, and practical vendor selection without treating lysosomal fluorescence as a standalone viability measurement.
-
EPZ5676: A Selective DOT1L Inhibitor Workflow
2026-09-04
Build reproducible biochemical, chromatin, and leukemia-cell workflows around EPZ5676, a highly selective DOT1L inhibitor. Practical handling, dosing, controls, and troubleshooting guidance help connect H3K79 methylation inhibition with MLL-fusion biology without overstating translational evidence.
-
NHS-Biotin for Translational Protein Engineering
2026-09-03
NHS-Biotin connects precise amine-reactive labeling with modern protein-engineering workflows. This thought-leadership guide explains how N-hydroxysuccinimido biotin can help researchers interrogate nanobody assembly, preserve assay interpretability, and advance candidates toward translational validation.
-
SMAD3 Inhibition Lowers ADAMTS-5 in Early OA
2026-09-03
Xiang et al. showed that pharmacological SMAD3 inhibition with SIS3 lowers ADAMTS-5 in chondrocytes and rat osteoarthritis cartilage, while increasing cartilage-associated miRNA-140. The findings identify a potentially important SMAD3–miRNA-140–ADAMTS-5 regulatory axis in early osteoarthritis, although the proposed mediation requires further genetic and mechanistic validation.